维普期刊资源整合服务平台（V6.5）

479篇 您的检索式：作者名="Fonseca V"

选中清除导出查看参考文献查看引证文献引用追踪共24页首页上一页第1页下一页末页 /24 跳转

	题名	作者	年代	出处	被引量
1	2型糖尿病与肝胆疾病显示文摘	Tolman KG Fonseca V Daipiaz A 马晓伟	2006	中国糖尿病杂志2006，14，5：	11
2	Therapeutic targets to reduce cardiovascular disease in type 2 diabetes 显示文摘	DESOUZA C FONSECA V	2009	Nat Rev Drug Discov2009，8，：	1
3	Nontraditional risk factors for cardiovascular disease in diabetes 显示文摘	Fonseca V Desouza C Asnani S	2004	Endocrine Reviews2004，25，1：	1
4	Nontraditional risk factors for cardiovascular disease in diabetes显示文摘	Fonseca V Desouzo C Asnani S	2004	Endocrine Reviews2004，25，：	1
5	Safty of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke显示文摘	Battistella V de Freitas GR da Fonseca LM	2011	Regen Med2011，6，1：	1
6	Hypoglycemia, diabetes, andcardiovascular events显示文摘	Desouza CV Bolli GB Fonseca V	2010	Diabetes Care2010，33，6：	1
7	One-daily human Glp-1 analog liraglutide reduces systoic blood pressure-a meta analysis of six dinical trials(LEAD)显示文摘	Fonseca V Madsbad S Falahati A	2009	Diabetes2009，58，1：	1
8	Diabetic retinopathy: A review for the primary care phy sician显示文摘	Fonseca V Munshi M Merin LM	1996	South Med J1996，89，：	1
9	Therapeutic approaches to target inflammation in type 2 diabetes显示文摘	Goldfine AB Fonseca V Shoelson SE	2011	J Clin Chem2011，57，2：	1
10	Efficacy and safety of Sitagliptin added to ongoing metformin and pioglitazone combination therapy in a randomized, placebo-controlled, 26- week trim in patients with type 2 diabetes 显示文摘	Fonseca V Staels B Morgan JD 2nd	2013	J Diabetes Complicatians2013，27，2：	1
11	Biodegradability enhancement of a leachate after biological lagooning using a solar driven photo-Fenton reaction,and further combination with an activated sludge biological process,at pre-industrial scale显示文摘	Silva T F C V Fonseca A Saraiva I	2013	Water Research2013，47，10：	1
12	Catalytic production and purification of nanotubules having fullerence-seale diameter显示文摘	Vanov V I Fonseca A Nagy J B	1995	Carbon1995，33，12：	1
13	The effect of glucose and insulin on the activity of methylene tetrahydrofolate reductase and cystathionine-beta-synthase: studies in hepatocytes 显示文摘	Dicker-Brown A Fonseca V A Fink L M	2001	Atherosclerosis2001，158，2：	1
14	Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial显示文摘	Bakris GL Fonseca V Katholi RE	2004	JAMA2004，292，18：	1
15	Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes 显示文摘	Fonseca V Schweizer A Albrecht D	2007	Diabetologia2007，50，：	1
16	Hyperhomocysteinemia-an emerging and important risk factor for thromboembolic and cardiovascular disease显示文摘	Guba SC Fink LM Fonseca V	1996	Am J Clin Chem Pathol1996，106，6：	1
17	Demographic analyses of the effects of carvedilol vs metoprolol on glycemic control and insulin sensitivity in patients with type 2 diabetes and hypertension in the Gly- cemic Effects in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) study 显示文摘	Phillips RA Fonseca V Katholi RE	2008	J Cardiometab Syndr2008，3，：	1
18	Nontraditional risk factors for cardiovascular disease in diabetes显示文摘	Fonseca V Desouza C Asnani S	2004	Endocr Rev2004，25，1：	1
19	Hypoglycemia, diabetes, and cardiovascular events 显示文摘	Desouza CV Bolli GB Fonseca V	2010	Diabetes Care2010，33，：	1
20	Addition of vilda- gliptin to insulin improves glycaemic control in type 2 diabetes 显示文摘	Fonseca V Schweizer A Albrecht D	2007	Diabectologia2007，50，11：	1

返回顶部每页显示：

共24页首页上一页第1页下一页末页 /24 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示